Gregory Gene Freitag
Gregory Gene Freitag's purchase track record
Gregory Gene Freitag has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/28/2025 | PDSB | $25K | +3.8% | -6.8% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Axogen Receives New Analyst Coverage and Valuation Upside. Axogen has attracted new analyst coverage from Robinhood and B of A Securities, both issuing bullish notes and setting price targets around $52. A Yahoo analysis suggests the stock may be about 26% undervalued on cash‑flow grounds, while the company has fallen 22.6% in the past month. These developments highlight renewed investor interest and potential upside relative to recent price action.
Transaction History
| PDSB | ▲ Buy | Open Market | 15,060 | $25K | 2/28/2025 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 11,904 | $0 | 6/4/2024 | View on chart |
| AXGN | ▼ Sell | Open Market | 25,000 | $225K | 3/7/2024 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 6,459 | $0 | 6/1/2023 | View on chart |
| AXGN | ▼ Sell | Open Market | 29,480 | $258K | 6/1/2023 | View on chart |
| AXGN | ▼ Sell | Open Market | 12,500 | $108K | 6/1/2023 | View on chart |
| AXGN | ▼ Sell | Open Market | 2,828 | $26K | 5/23/2023 | View on chart |
| AXGN | ▼ Sell | Open Market | 4,640 | $43K | 5/23/2023 | View on chart |
| AXGN | ▼ Sell | Open Market | 13,000 | $166K | 11/14/2022 | View on chart |
| AXGN | ▼ Sell | Open Market | 13,000 | $163K | 11/8/2022 | View on chart |
| AXGN | ▼ Sell | Open Market | 8,886 | $86K | 8/10/2022 | View on chart |
| AXGN | ▼ Sell | Open Market | 13,046 | $135K | 8/8/2022 | View on chart |
| AXGN | ▼ Sell | Open Market | 24,000 | $255K | 8/4/2022 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 83,000 | $281K | 7/25/2022 | View on chart |
| AXGN | ▼ Sell | Tax Withholding | 30,296 | $281K | 7/25/2022 | View on chart |
| AXGN | ▲ Buy | Option Exercise | 3,036 | $0 | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
No recent news for PDSB in the past week
PDSB has not issued any new corporate announcements or earnings releases in the last seven days. The stock is trading near its 52‑week low, with an RSI of 59.5 and a support level at $0.21. Analysts maintain an average target of $4.75, while the 52‑week range spans $0.20 to $1.55. No significant events have impacted the company’s outlook recently.
No recent news for PDSB in the past week. PDSB has not issued any new corporate announcements or earnings releases in the last seven days. The stock is trading near its 52‑week low, with an RSI of 59.5 and a support level at $0.21. Analysts maintain an average target of $4.75, while the 52‑week range spans $0.20 to $1.55. No significant events have impacted the company’s outlook recently.